Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Moroctocog alfa 2,000unit inj vials
0211000I0AAAZAZ
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 250unit inj pfs
0211000I0AAATAT
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 250unit inj vials
0211000I0AAAYAY
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 3,000unit inj pfs
0211000I0AAARAR
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 500unit inj pfs
0211000I0AAAUAU
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 500unit inj vials
0211000I0AABABA
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Morphine 0.1% gel
0407020Q0AAFSFS
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine 0.2% gel
0407020Q0AAFUFU
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine 2% gel
0407020Q0AAFQFQ
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine 200mg capsules
0407020Q0AADXDX
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine 200mg modified-release granules sachets sugar free
0407020Q0AADEDE
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine 20mg modified-release capsules
0407020Q0AADZDZ
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine 30mg capsules
0407020Q0AADSDS
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine 50mg modified-release capsules
0407020Q0AAEAEA
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine 60mg capsules
0407020Q0AADTDT
|
Morphine sulfate | Morphine sulfate | Central Nervous System | No data available |
|
Morphine and Cocaine elixir
0407020P0AAAIAI
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 1.5mg/5ml oral solution
0407020P0AAAWAW
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 100mg/5ml oral solution
0407020P0AAAPAP
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 10mg suppositories
0407020P0AAAQAQ
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 10mg/10ml inj pre-filled syringes
0407020P0AAAZAZ
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 15mg suppositories
0407020P0AAABAB
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 15mg/5ml oral solution
0407020P0AAAXAX
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 20mg/5ml oral solution
0407020P0AAAYAY
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 25mg/5ml oral solution
0407020P0AAATAT
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
|
Morphine hydrochloride 30mg suppositories
0407020P0AAACAC
|
Morphine hydrochloride | Morphine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.